Posaconazole Tablet, Delayed Release
Product Images NDC 70748-258

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 70748-258). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Posaconazole (B8e6d7a9 Ab88 4845 B08d 513ebd10a0ea 01)

Chemical structure of posaconazole, showing its molecular framework with aromatic rings, fluorine atoms, nitrogen-containing rings, and hydroxyl group.*

FDA Label Image

60s Bottle (B8e6d7a9 Ab88 4845 B08d 513ebd10a0ea 02)

Posaconazole delayed-release tablets, 100 mg strength, in a label displaying 60 tablets per bottle. The label states each tablet contains 100 mg Posaconazole and notes that Posaconazole tablets and Noxafil oral suspension are not interchangeable due to dosing differences. Manufactured for Lupin Pharmaceuticals, Inc. and by AET Laboratories, India. Includes storage instructions and barcode.*

FDA Label Image

Image (B8e6d7a9 Ab88 4845 B08d 513ebd10a0ea 03)

Label for Posaconazole Delayed-Release Tablets 100 mg, oral dosage form. The label indicates 60 tablets per container, manufactured for Lupin Pharmaceuticals, Inc. It includes storage instructions and a note that Posaconazole tablets are not interchangeable with Noxafil oral suspension. The label shows the NDC 70748-258-07 and includes a picture of a tablet imprinted with '100P'.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.